View Author
heart protein phosphorylation heart failure failure filament cardiomyocyte troponin function force sarcomeric myocardium kinase myo filament signi ficantly myosin 2þ sensitivity signi muscle mlc 2 phosphorylation troponin i change isoform sarcomeric function donor dysfunction non-failing tissue model difference animal sarcomeric proteins protein kinase ficantly erasmus university rotterdam patient sensitivity 2?-sensitivity effect reduction expression force development figure study sample circulation activity end-stage velden myo filament function fi lament stiffness increase analysis sarcomeric dysfunction boontje nm mouse phosphatase end-stage heart failure chain cmybp-c phosphorylation status infarction cardiomyocyte stiffness alteration contractile myo filament proteins tension tombe pp development pca 50 zaremba r physiol disease foetal ctnt pka-mediated phosphorylation motil myo filament dysfunction foetal shift
2 Most Recent Publications
|
Myofilament dysfunction in cardiac disease from mice to men
(Article)
Hamdani, N. Waard, M.C. de Duncker, D.J.G.M. Borbely, A. Papp, Z. Paulus, W. Stienen, G.J.M. Marston, S.B. Velden, J. van der Messer, A.E. Boontje, N.M. Kooij, V. Dijk, S.J. van Versteilen, A. Lamberts, R. Merkus, D. Remedios, C. dos |
2008-12-01
|
|
Sarcomeric dysfunction in heart failure
(Article)
Hamdani, N. Kooij, V. Dijk, S.J. van Merkus, D. Paulus, W.J. Remedios, C.D. Duncker, D.J.G.M. Stienen, G.J.M. Velden, J. van der |
2008-03-01
|